MedTrace Logo

A Technology-Enhanced Approach for Implementing Evidence-Based Practices in Child Welfare

NCT02430337 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2020-01-22

Study results available
· View outcomes & findings →

Summary

In this study, a computer-assisted adaptation of SafeCare, an evidence-based home visiting program, will be developed and tested in child welfare. This approach will assist home visitors with the delivery of SafeCare to families, with the goal of improving provider fidelity and implementation success. In the computer-assisted SafeCare sessions, a portion of the session will be delivered on a tablet computer that the home visitor brings to the family's home. The computer software will deliver the educational piece, or explain a piece of each session, along with modeling videos of the skills. The home visitor will follow up with the practice and feedback portions of the session. A randomized feasibility trial will be conducted to test the technology-based approach against the standard SafeCare implementation approach in terms of feasibility of implementation, provider job demands, and resources, as well as client outcomes such as skill acquisition and mental health.

Conditions

  • Child Maltreatment
  • Implementation
  • Technology

Interventions

BEHAVIORAL

Technology-Assisted SafeCare

A technology-enhanced version of SafeCare

BEHAVIORAL

SafeCare

SafeCare, an evidence-based home visiting program

Sponsors & Collaborators

  • Georgia State University

    lead OTHER

Principal Investigators

  • Shannon Self-Brown, PhD · Georgia State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-06-30
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02430337 on ClinicalTrials.gov